Adora Cheung retweeted
I’m so excited to share this update on @Conception –
We’ve generated the first early human eggs derived from stem cells.
This is a big deal -- the potential to redefine fertility is real.
Adora Cheung retweeted
You. On stage. Pitching your doc to the people who greenlight, fund, and distribute films...This is DOC NYC PRO's Pitch Day!
Co-presented by @outlierfilmfund. Submissions close August 7.
Apply: filmfreeway.com/DOCNYC-PITCH
Adora Cheung retweeted
It took us two years to grow from $10 mm to $100 mm in Annual Recurring Revenue and 15 months to reach $200 mm. Nine months later, we crossed $300 mm. Vanta’s growth rate increased each of the past four quarters – compounding really is the eighth wonder of the world!
“But wait,” you might be thinking. “How does a software company founded before 2022 *increase* its growth rate?” Narrative violation!
Adora Cheung retweeted
Every VC likes to pretend their companies will IPO.
This has real implications.
To quantify their potential investment opportunity VCs match a startup to similar public companies. This helps inform the current round valuation.
Unless of course it is a super hot round. Then nothing matters.
We build a tool to help founders get ahead and shape the public comp narrative, Public Comps, now in the Venture Codex. Link next.
Adora Cheung retweeted
Most people taking GLP-1s unintentionally under-eat protein because their appetite is so suppressed. And without the right strategy, you can lose more muscle than you need to.
The clinical data points to three key levers to maintain muscle mass:
1. Protein intake. Aim for 1.0–1.5 g/kg/day. In one 12-week study, GLP-1 users who hit these targets with exercise lost 7.4 kg with zero fat-free mass loss.
2. Resistance training. Research shows that without strength training, extra protein just gets stored as fat. Aim for 2-3x/week covering major muscle groups.
3. Track your body composition. A DEXA scan before starting (and periodically during) gives you real data on whether your approach is working.
The bottom line: GLP-1 muscle loss is real but manageable, especially if you’re proactive.
instalab.com/glp1
Adora Cheung retweeted
We just made a major upgrade to Venture Codex.
143k+ funding rounds.
88k+ companies.
53k+ investors.
163 countries.
That’s 15× more data to help founders see how capital is actually raised.
Link next
Adora Cheung retweeted
Replying to @_AshleyRichmond
Absolutely. Most people don't realize how much sleep affects fat / muscle loss.
In research, cutting sleep from 8.5 hours to 5.5 hours per night during calorie-restricted diet reduced fat loss by 55% and increased lean mass loss by 60%. More hunger; less fat oxidation:
acpjournals.org/doi/10.7326/…
Adora Cheung retweeted
Repatha (evolocumab) is far more powerful than statins alone. When added on top of statin therapy, it can lower LDL cholesterol by ~60% and reduce major cardiovascular events by ~15%. As its price tag continues to drop, we’re excited to see how many lives this medication will save.
Adora Cheung retweeted
Your APOE genotype plays a critical role in how your brain processes fats and repairs neurons. Each of us inherits two copies of this gene, one from each parent, and the specific combination we carry (ε2, ε3, or ε4) can influence how our brains age over time.
Certain APOE variants, such as ε4, are linked to a higher risk of Alzheimer’s disease. But your genes do not necessarily determine your destiny. Many people with ε4 alleles never develop dementia, especially when they take proactive steps to protect their brain:
- Regular moderate-to-vigorous physical activity
- Mediterranean-style diet
- Quality time with family and friends
- Consistent, high-quality sleep
- Avoid smoking
- Limit alcohol intake
- Manage risk factors like blood pressure and apoB
Understanding your genotype empowers you to take control of your brain health and make informed, preventive choices. If you’d like to learn more about your APOE status, schedule a blood test today: instalab.com/test/apoe
Adora Cheung retweeted
If you're 40 or older and haven't had a CAC scan, get one. It's the most definitive way to see how much plaque has already clogged your heart's arteries.
ApoB predicts future risk.
CAC reveals existing risk.
instalab.com/cac
Adora Cheung retweeted
A new way to get very early detection of colon cancer using cell-free RNA (instead of DNA) @NatureBiotech
nature.com/articles/s41587-0…
Adora Cheung retweeted
I'm rewriting the Series A Guide.
Markets have changed in the last five years and advice should change along with it.
If you've raised an A in the last 6 months, I'd be grateful for 30 minutes of your time.
DMs are open.
Adora Cheung retweeted
An important step towards helping Americans incorporate healthful seafood choices into their diets in a sustainable way. This clearance demonstrates the viability of the regulatory pathway that the FDA has created for these products
share.google/STW8qPgcEA8ys3G…
Adora Cheung retweeted
What if shopping felt like Pinterest, but worked?
You can now vibe shop for your home — and our AI saves you hundreds (sometimes thousands) of dollars.
So proud of the team that made this real.💪
producthunt.com/posts/spoken…
Adora Cheung retweeted
One of the most egregious examples of paid-for politicians forcibly holding back a wildly beneficial technology to protect corporate interests. It is an affront to freedom, stripping citizens of the option to spare animals and the environment in their meat consumption.
Adora Cheung retweeted
If you're taking creatine, monitor your kidney function with a blood test called Cystatin C, which is any case a much better reflection of kidney function than creatinine regardless of supplementation or not.
Creatine isn’t harming your kidneys—elevated creatinine levels from supplementation are completely normal
Clinical studies have consistently shown no adverse effects of creatine on kidney, liver, or cardiovascular health, even at doses as high as 11 grams per day
The confusion stems from a common metabolic byproduct: creatinine
When creatine is metabolized, it forms creatinine, which is excreted by the kidneys (and standard lab tests flag elevated creatinine as a possible sign of kidney dysfunction)
So if you’re supplementing with creatine, higher blood creatinine is expected and harmless (it’s not kidney damage)
Adora Cheung retweeted
We are excited to announce the Teal Wand is FDA-approved and coming soon! For the first time, women will be able to collect a sample at home to screen for cervical cancer. Same test and accuracy as the doctor’s office, but no speculum required. bit.ly/4jKaL69
Adora Cheung retweeted
Today, NIH announced a new initiative to expand innovative, human-based science while reducing the use of animals in research. This aligns with @US_FDA’s initiative to reduce testing in animals. bit.ly/4jYd4T2
Adora Cheung retweeted
Personal/Work Update!
I'm joining @generalcatalyst as a Managing Director to lead seed in the US.
Over the past five years I've been incredibly fortunate to partner with some incredible founders while building out Wayfinder.
At the same time, I believe the opportunity presented by partnering with GC can have an even larger impact on the startup ecosystem. Of all the larger, full-stack investors I’ve met over the years, GC seems to truly appreciate how important it is to do seed in a focused manner, and NOT as an option call on a future Series A. We'll be putting all of the resources of the GC platform (and some unique things for seed founders — stay tuned!) on day one.
The world is changing fast, and it has never been a better time to start a startup. If you're working on something new, no matter how early, I'd love to chat!
Today, I am really excited to announce that Yuri Sagalov (@yuris) is joining @generalcatalyst as a Managing Director to lead our seed efforts in the US.
I have often said that our core at GC is early stage investing. Partnering with the most ambitious founders at seed enables us to fulfill our own ambition to transform industries.
Yuri founded Wayfinder Ventures and has backed incredible companies like Supabase, Verse Medical, Stoke Space, Decagon, Finni Health and many more. Previously, he spent 5 years at @ycombinator as a Visiting Group Partner and served seed stage founders with real passion.
At GC, we have been striving to back founders at Seed with the same rigor, focus and passion as smaller firms who dedicate to seed as their only focus. We are keen to continue to partner with them as we improve.
I feel really fortunate that Yuri (Wayfinder), Jeannette (La Famiglia) and Neeraj (Venture Highway) as founders of seed firms have all decided to bring their entrepreneurial energy to shape our seed value proposition at GC to be what the world's best founders deserve from a company like ours.
Our seed proposition is to help founders figure out their business in the midst of uncertainty and ambiguity, and lay the foundation to endure for the long term. Seed is NOT an option call for future series A, nor is it the phase to impose undue governance - it's a time to lock arms with founders to inspire talent to join, tackle the highest risks and build conviction to make it their life's work.
One important call out about our seed proposition going forward is that we aim to consistently do pro rata in the next financing after leading or co-leading a seed so that we eliminate any "signalling risk".
Yuri - Welcome to GC and thanks for helping us continue to get better at our core.
Adora Cheung retweeted
Remember when 2 activists threw soup on a Van Gogh, pissing off the entire world? Sabotage takes you inside a controversial climate group – and their connection to an American dynasty.
From @goodluck_media & @weareyellowdot, listen to Season 1 wherever you get your podcasts!






























